Overview
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 203 days for 2020).
- 202507/10/2026
- 202415/07/2025
- 202326/06/2024
- 202230/06/2023
- 202118/10/2022
- 202006/05/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
If the company's management board consists of 1 (one) person, the sole member of the management board is authorized to represent the company independently. If the company's management board consists of 2 (two) or more members of the management board, the company is represented as follows: (i) if no Vice-President of the Management Board for Finance has been appointed, each member of the management board is authorized to submit declarations and sign documents on behalf of the company independently; (ii) if a Vice-President of the Management Board for Finance has been appointed, the representation of the company in every case requires the joint action of that Vice-President of the Management Board for Finance together with another member of the management board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sunfish Poland i Gmbh & Co. Kg | 94 | $1,269.58 | 18.9899% |
Stanisław Mateusz Gizińskiage 29 | 128 | $1,728.80 | 25.8586% |
Piotr Grzegorczykage 29 | 128 | $1,728.80 | 25.8586% |
Grzegorz Preibischage 30 | 128 | $1,728.80 | 25.8586% |
Others | 17 | $229.61 | 3.4343% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-09-01.
09 1600 1462 1891 2941 1000 0006- 36 1600 1462 1891 2941 1000 0005
- 95 1600 1462 1891 2941 1000 0010
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $1,937,221.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 17, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Fundacja Przedsiębiorczości Technologicznej | |
| Apr 6, 2022 | Aid for SME access to finance — risk finance aid | –– | PFR Ventures sp. z o.o. | |
| Nov 5, 2021 | Aid for research and development projects: industrial research | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-09-01 | CovidGenomics - wielomodułowe narzędzie (system) wspierający proces opracowywania szczepionek mRNA z modułami do predykcji ewolucji wirusów szybko- i wolnomutujących (w tym SARS-CoV-2) | $440.7K$440,659 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Quantum Innovationssp. z o.o. | $167,489.61 | quantuminnovations.pl | ||
| PellicarnosS.A. | $135,043.43 | pellicarnos.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| AI Corelabsp. z o.o. | $106,857.00 | aicorelab.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Orphinic ScientificS.A. | $42,972.42 | orphinic.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-03-25 | Share capital increase (22,800.00 PLN → 24,750.00 PLN) | |
| 2024-03-25 | Name change (Cgen → Deepflare) | |
| 2023-09-12 | Address change (Ul. Przeskok 2, 00-032, Warszawa → Ul. Złota 7/28, 00-019, Warszawa) | |
| 2022-09-02 | Address change (Ul. Włodarzewska 76j/57, 02-393, Warszawa → Ul. Przeskok 2, 00-032, Warszawa) | |
| 2022-06-03 | Share capital increase (10,000.00 PLN → 22,800.00 PLN) |
FAQ
Last updated: 2026-10-07